Visalytics
Visalytics
approved EB-2 (NIW)

Research Fellow

Biomedical Sciences · India · 2023-03-23

Processing Time
111 days
Decision Date
2023-03-23
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in biomedical sciences, specifically optimizing therapeutic strategies for acute myeloid leukemia by elucidating molecular mechanisms. Her work focuses on identifying leukemia stem cell markers and critical transcription factors to develop advanced treatment strategies for therapy-resistant quiescent stem cells in blood cancer.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The petitioner's research on leukemia stem cell markers and treatment strategies for blood cancer was found to have significant merit for the U.S. healthcare system.

2 Well-positioned to Advance the Endeavor Met

With 13 publications, 383 citations, and 11 peer reviews, the petitioner demonstrated a high level of expertise and influence in the biomedical field.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's contributions to cancer research and the support from international experts made it beneficial to the U.S. to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in applied biology and a strong record of 13 peer-reviewed articles in high-impact journals. She demonstrated significant influence through 383 citations from 37 countries, 11 peer review assignments, and research funding from the Indian Council of Medical Research and the German Research Foundation. All three Dhanasar prongs were satisfied through the totality of this evidence.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions

Similar Cases

Postdoctoral Researcher

Biotechnology · Vietnam

WeGreened EB-2 (NIW) approved
Pennsylvania 103 days 2023-05-26
The petitioner proposes to introduce, evaluate, and refine innovative precision therapies to improve the treatment of leukemia and other blood cancers. This work focuses on developing targeted medical interventions to enhance clinical outcomes for patients with hematologic malignancies.
View Case

Scientist

Healthcare · Bangladesh

WeGreened EB-2 (NIW) approved
Japan 126 days 2022-04-15
The petitioner proposes to continue her research on investigating the pathways that regulate healthy and cancerous cells. This work aims to develop new therapeutic drugs and organ transplant technologies, specifically focusing on identifying genetic markers associated with cancerous cell growth and proliferation.
View Case

Assistant Professor

Healthcare · China

WeGreened EB-2 (NIW) approved
Pennsylvania 40 days 2025-05-13
The petitioner proposes to enhance CAR-T cell therapy for hematological malignancies by integrating laboratory research with patient-centered clinical trials. The work focuses on closing the translational gap to bring immunotherapy discoveries into clinical practice for leukemia and other blood cancers. The goal is to develop therapies that are more precise, responsive, and accessible to patients.
View Case

Scientist

Biotechnology · Russia

WeGreened EB-2 (NIW) approved
Oregon 51 days 2025-02-27
The petitioner proposes to develop a deterministic model using epigenetic signatures to identify individuals at high risk for the onset and relapse of acute myeloid leukemia (AML). This research focuses on advancing precision in early diagnosis through complex molecular profiling to pinpoint early biological markers. The work aims to enable targeted clinical interventions before symptoms escalate, thereby reducing mortality and healthcare disparities associated with aggressive blood cancers.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-03-23.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 111 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist